A5054030296- Nanoparticle-Based Drug Delivery
- Hydrogels: synthesis, properties, applications
- 3D Printing in Biomedical Research
- Graphene and Nanomaterials Applications
- Nanoplatforms for cancer theranostics
- Electrospun Nanofibers in Biomedical Applications
- Supercapacitor Materials and Fabrication
- Wound Healing and Treatments
- Gold and Silver Nanoparticles Synthesis and Applications
- Advanced biosensing and bioanalysis techniques
- Bone Tissue Engineering Materials
- Additive Manufacturing and 3D Printing Technologies
- Characterization and Applications of Magnetic Nanoparticles
- Advanced Sensor and Energy Harvesting Materials
- Conducting polymers and applications
- Nanomaterials for catalytic reactions
- Cancer Treatment and Pharmacology
- Advancements in Battery Materials
- MXene and MAX Phase Materials
- Agriculture Sustainability and Environmental Impact
- RNA Interference and Gene Delivery
- biodegradable polymer synthesis and properties
- Innovative Microfluidic and Catalytic Techniques Innovation
- Advanced Drug Delivery Systems
- Advanced Cellulose Research Studies
Yeungnam University
2021-2025
Islamic Azad University North Tehran Branch
2024
Institute of Nano Science and Technology
2019-2023
Indian Institute of Technology Mandi
2021-2023
Indian Institute of Science Education and Research Mohali
2019-2021
India Habitat Centre
2020-2021
Guru Gobind Singh Indraprastha University
2015-2020
Optica
2020
In this paper, a spotlight is shown on polysaccharides based biomaterials which have surfaced as versatile platform for different biomedical applications including drug delivery and tissue regeneration. Herein, structure unique properties of are described along with various functionalization strategies. Additionally, brief overview physical chemical crosslinking approaches to design derived provided. Due their inherent biocompatible biodegradable properties, being extensively explored...
Exploiting novel crosslinking chemistry, this study pioneers the use of waterborne polyurethane (WPU) to chemically crosslink porcine-derived gelatin, producing enhanced gelatin hydrogel films through a solvent-casting method. Our innovative approach harnesses reactive isocyanate groups WPU, coupling them effectively with gelatin's hydroxyl and primary amino form robust urea urethane linkages within matrix. This method not only preserves intrinsic elasticity but also significantly augments...
The current article reports on providing surface modification of magnetic nanoparticles with gold to provide stability against aggregation. Gold-coated magnetite were synthesised combine both as well plasma resonance (SPR) properties in a single moiety. nanocomposites produced by reduction (using ascorbic acid) chloride the iron oxide nanoparticles. Ascorbic acid not only acts reducing agent, but also oxidised form i.e. Dehydro-ascorbic capping agent impart gold-coated nanocomposites....
Herein, we present disulfide crosslinked dextran/eudragit S-100 nanoparticles (DEEU NPs) (≈55 nm) for colorectal cancer treatment. These redox environment sensitive DEEU NPs are synthesized by simple oxidation of thiolated polymers in air. This approach allows avoiding the use any additional chemical crosslinker. have high encapsulation efficiency doxorubicin (DOX) model drug (≈95%). The prepared owing to units and exhibit ≈80% DOX release reducing GSH. Additionally, DOX-DEEU display...
Advancements in polymers have made significant contribution diverse application‐oriented fields. The multidisciplinary application of generates a range strategies, which is applicable wide biomedicines. Polymeric compounds such as hydrogels been explored globally potent biomaterial that can furnish essential attributes due to their three‐dimensional (3D) soft and highly hydrophilic polymeric network. These used extensively various applications biocompatible, biodegradable, biosorption...
Covalently bonded Eudragit S-100 (EU) and chitosan (CS) based colon-specific nanoparticles (CSE NPs) were fabricated as drug carriers for treating colorectal cancers through oral administration. Thiolation of EU CS prevents the usage cross-linking agent. This gives an advantage over shortcomings existing EU- CS-based delivery systems that are associated with large sized a broad range size distribution. Paclitaxel (PTX)-loaded CSE NPs presented efficacy 8–10% after 48 h treatment on HCT 116...